We found that TJ proteins expression in patients with metformin treatment for T2DM were higher than those in patients with insulin treatment for T2DM (Fig. 3F and G), suggesting that metformin may participate in maintaining intestinal barrier function in UC patients. This evidence concerns the gene INS and type 2 diabetes mellitus.